Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · IEX Real-Time Price · USD
45.39
+0.18 (0.40%)
May 17, 2024, 4:00 PM EDT - Market closed
PRAX Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for PRAX stock have an average target of 105.8, with a low estimate of 29 and a high estimate of 150. The average target predicts an increase of 133.09% from the current stock price of 45.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $150 | Strong Buy | Maintains | $150 | +230.47% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +131.33% | May 14, 2024 |
| Baird | Baird | Buy Initiates $117 | Buy | Initiates | $117 | +157.77% | May 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +131.33% | Apr 26, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $75 → $128 | Strong Buy | Maintains | $75 → $128 | +182.00% | Mar 26, 2024 |
Financial Forecast
Revenue This Year
2.35M
from 2.45M
Decreased by -4.13%
Revenue Next Year
1.50M
from 2.35M
Decreased by -35.98%
EPS This Year
-9.16
from -18.69
EPS Next Year
-9.85
from -9.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 6.1M | 268.7M | 599.3M | 1.1B |
| Avg | 2.3M | 1.5M | 82.9M | 188.0M | 401.3M |
| Low | n/a | n/a | 784,000 | 44.2M | 147.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 114.5% | 161.2% | 17,790.1% | 622.9% | 477.7% |
| Avg | -4.1% | -36.0% | 5,419.2% | 126.8% | 113.5% |
| Low | - | - | -47.8% | -46.7% | -21.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.63 | -6.48 | 4.49 | 24.70 | 46.60 |
| Avg | -9.16 | -9.85 | -5.91 | 0.28 | 12.50 |
| Low | -9.85 | -12.67 | -15.92 | -10.78 | -1.90 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 16,512.8% |
| Avg | - | - | - | - | 4,356.4% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.